FDA Approves Merck HIV Drug, Challenging Gilead Sciences
FDA Approves Merck’s Idvynso: A New Alternative for HIV Patients Switching from Biktarvy In a move that reshapes the competitive landscape of antiretroviral therapy, the U.S. Food and Drug Administration has granted a FDA nod for Merck’s HIV drug Idvynso. This approval provides a vital new lifeline for patients who have struggled with existing treatments. … Read more
